Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 5/2011

01.10.2011 | Original Article

Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients

verfasst von: María-Socorro Pérez-Poyato, Montserrat Milà Recansens, Isidre Ferrer Abizanda, Raquel Montero Sánchez, Laia Rodríguez-Revenga, Victoria Cusí Sánchez, M. Mar García González, Rosario Domingo Jiménez, Rafael Camino León, Ramón Velázquez Fragua, Antonio Martínez-Bermejo, Mercè Pineda Marfà

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Juvenile neuronal ceroid lipofuscinosis (JNCL, NCL3, Batten disease) is usually caused by a 1.02-kb deletion in the CLN3 gene. Mutations in the CLN1 gene may be associated with a variant form of JNCL (vJNCL). We report the clinical course and molecular studies in 24 patients with JNCL collected from 1975 to 2010 with the aim of assessing the natural history of the disorder and phenotype/genotype correlations.

Patients and methods

Patients were classified into the groups of vJNCL with mutations in the CLN1 gene and/or granular osmiophilic deposit (GROD) inclusion bodies (n = 11) and classic JNCL (cJNCL) with mutations in the CLN3 gene and/or fingerprint (FP) profiles (n = 13). Psychomotor impairment included regression of acquired skills, cognitive decline, and clinical manifestations of the disease. We used Kaplan-Meier analyses to estimate the age of onset of psychomotor impairment.

Results

Patients with vJNCL showed learning delay at an earlier age (median 4 years, 95% confidence interval [CI] 3.1–4.8) than those in the cJNCL group (median 8 years, 95% CI 6.2–9.7) (P = 0.001) and regression of acquired skills at a younger age. Patients with vJNCL showed a more severe and progressive clinical course than those with cJNCL. There may be a Gypsy ancestry for V181L missense mutation in the CLN1 gene.

Conclusions

The rate of disease progression may be useful to diagnose vJNCL or cJNCL, which should be confirmed by molecular studies in CLN1/CLN3 genes. Further studies of genotype/phenotype correlation will be helpful for understanding the pathogenesis of this disease.
Literatur
Zurück zum Zitat Aberg L, Järvelä I, Rapola J et al. (1998) Atypical juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposit-like inclusions in the autonomic nerve cells of the gut wall. Acta Neuropathol 95:306–312PubMedCrossRef Aberg L, Järvelä I, Rapola J et al. (1998) Atypical juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposit-like inclusions in the autonomic nerve cells of the gut wall. Acta Neuropathol 95:306–312PubMedCrossRef
Zurück zum Zitat Aberg L, Kirveskari E, Santavuori P (1999) Lamotrigine therapy in juvenile neuronal ceroid lipofuscinosis. Epilepsia 40:796–799PubMedCrossRef Aberg L, Kirveskari E, Santavuori P (1999) Lamotrigine therapy in juvenile neuronal ceroid lipofuscinosis. Epilepsia 40:796–799PubMedCrossRef
Zurück zum Zitat Aberg LE, Bäckman M, Kirveskari E, Santavuori P (2000) Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis. Epilepsia 41:1296–1302PubMedCrossRef Aberg LE, Bäckman M, Kirveskari E, Santavuori P (2000) Epilepsy and antiepileptic drug therapy in juvenile neuronal ceroid lipofuscinosis. Epilepsia 41:1296–1302PubMedCrossRef
Zurück zum Zitat Aberg L, Lauronen L, Hämäläinen J, Mole SE, Autti T (2009) A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course. Pediatr Neurol 40:134–137PubMedCrossRef Aberg L, Lauronen L, Hämäläinen J, Mole SE, Autti T (2009) A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course. Pediatr Neurol 40:134–137PubMedCrossRef
Zurück zum Zitat Autti TH, Hämäläinen J, Mannerkoski M, Van Leemput KV, Aberg LE (2008) JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence. J Neurol 255:31226–31230CrossRef Autti TH, Hämäläinen J, Mannerkoski M, Van Leemput KV, Aberg LE (2008) JNCL patients show marked brain volume alterations on longitudinal MRI in adolescence. J Neurol 255:31226–31230CrossRef
Zurück zum Zitat Das AK, Becerra CH, Yi W et al. (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest 102:361–370PubMedCrossRef Das AK, Becerra CH, Yi W et al. (1998) Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. J Clin Invest 102:361–370PubMedCrossRef
Zurück zum Zitat Goebel HH, Sharp JD (1998) The neuronal ceroid-lipofuscinoses. Recent advances. Brain Pathol 8:151–162PubMedCrossRef Goebel HH, Sharp JD (1998) The neuronal ceroid-lipofuscinoses. Recent advances. Brain Pathol 8:151–162PubMedCrossRef
Zurück zum Zitat Goebel HH, Wisniewski KE (2004) Current state of clinical and morphological features in human NCL. Brain Pathol 14:61–69PubMedCrossRef Goebel HH, Wisniewski KE (2004) Current state of clinical and morphological features in human NCL. Brain Pathol 14:61–69PubMedCrossRef
Zurück zum Zitat Goebel HH, Mole SE, Lake BD (1999) The neuronal ceroid lipofuscinosis (Batten disease). In: IOS Press, ed. NCL in different European countries. On behalf of the European Concerted Action Group. Amsterdam, 128–142 Goebel HH, Mole SE, Lake BD (1999) The neuronal ceroid lipofuscinosis (Batten disease). In: IOS Press, ed. NCL in different European countries. On behalf of the European Concerted Action Group. Amsterdam, 128–142
Zurück zum Zitat Haltia M (2003) The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 62:1–13PubMed Haltia M (2003) The neuronal ceroid-lipofuscinoses. J Neuropathol Exp Neurol 62:1–13PubMed
Zurück zum Zitat Hofman IL, Taschner PE (1995) Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD). Am J Med Genet 57:165–167PubMedCrossRef Hofman IL, Taschner PE (1995) Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD). Am J Med Genet 57:165–167PubMedCrossRef
Zurück zum Zitat Hofmann SL, Das AK, Yi W, Lu JY, Wisniewski KE (1999) Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency. Mol Genet Metab 66:234–239PubMedCrossRef Hofmann SL, Das AK, Yi W, Lu JY, Wisniewski KE (1999) Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency. Mol Genet Metab 66:234–239PubMedCrossRef
Zurück zum Zitat Kälviäinen R, Eriksson K, Losekoot M et al. (2007) Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency. Eur J Neurol 14:369–372PubMedCrossRef Kälviäinen R, Eriksson K, Losekoot M et al. (2007) Juvenile-onset neuronal ceroid lipofuscinosis with infantile CLN1 mutation and palmitoyl-protein thioesterase deficiency. Eur J Neurol 14:369–372PubMedCrossRef
Zurück zum Zitat Lauronen L, Munroe PB, Järvelä I et al. (1999) Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology 52:360–365PubMed Lauronen L, Munroe PB, Järvelä I et al. (1999) Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis. Neurology 52:360–365PubMed
Zurück zum Zitat Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
Zurück zum Zitat Marshall FJ, de Blieck EA, Mink JW et al. (2005) A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology 65:275–279PubMedCrossRef Marshall FJ, de Blieck EA, Mink JW et al. (2005) A clinical rating scale for Batten disease: reliable and relevant for clinical trials. Neurology 65:275–279PubMedCrossRef
Zurück zum Zitat Mazzei R, Conforti FL, Magariello A et al. (2002) A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis. J Neurol 249:1398–1400PubMedCrossRef Mazzei R, Conforti FL, Magariello A et al. (2002) A novel mutation in the CLN1 gene in a patient with juvenile neuronal ceroid lipofuscinosis. J Neurol 249:1398–1400PubMedCrossRef
Zurück zum Zitat Mitchison HM, Hofmann SL, Becerra CH et al. (1998) Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum Mol Genet 7:291–297PubMedCrossRef Mitchison HM, Hofmann SL, Becerra CH et al. (1998) Mutations in the palmitoyl-protein thioesterase gene (PPT; CLN1) causing juvenile neuronal ceroid lipofuscinosis with granular osmiophilic deposits. Hum Mol Genet 7:291–297PubMedCrossRef
Zurück zum Zitat Mole S (2006) Neuronal ceroid lipofuscinoses (NCL). Eur J Paediatr Neurol 10:256–257CrossRef Mole S (2006) Neuronal ceroid lipofuscinoses (NCL). Eur J Paediatr Neurol 10:256–257CrossRef
Zurück zum Zitat Mole SE, Williams RE, Goebel HH (2005) Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6:107–126PubMedCrossRef Mole SE, Williams RE, Goebel HH (2005) Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 6:107–126PubMedCrossRef
Zurück zum Zitat Moore SJ, Buckley DJ, MacMillan A et al. (2008) The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet 74:213–222PubMedCrossRef Moore SJ, Buckley DJ, MacMillan A et al. (2008) The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet 74:213–222PubMedCrossRef
Zurück zum Zitat Munroe PB, Mitchison HM, O'Rawe AM et al. (1997) Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet 61:310–316PubMedCrossRef Munroe PB, Mitchison HM, O'Rawe AM et al. (1997) Spectrum of mutations in the Batten disease gene, CLN3. Am J Hum Genet 61:310–316PubMedCrossRef
Zurück zum Zitat Philippart M, Chugani HT, Bateman JB (1995) New Spielmeyer-Vogt variant with granular inclusions and early brain atrophy. Am J Med Genet 57:160–164PubMedCrossRef Philippart M, Chugani HT, Bateman JB (1995) New Spielmeyer-Vogt variant with granular inclusions and early brain atrophy. Am J Med Genet 57:160–164PubMedCrossRef
Zurück zum Zitat Santavuori P, Lauronen L, Kirveskari K, Aberg L, Sainio K (2000) Neuronal ceroid lipofuscinoses in childhood. Suppl Clin Neurophysiol 53:443–451PubMedCrossRef Santavuori P, Lauronen L, Kirveskari K, Aberg L, Sainio K (2000) Neuronal ceroid lipofuscinoses in childhood. Suppl Clin Neurophysiol 53:443–451PubMedCrossRef
Zurück zum Zitat Santavuori P, Vanhanen SL, Autti T (2001) Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol 5(Suppl A):157–161PubMedCrossRef Santavuori P, Vanhanen SL, Autti T (2001) Clinical and neuroradiological diagnostic aspects of neuronal ceroid lipofuscinoses disorders. Eur J Paediatr Neurol 5(Suppl A):157–161PubMedCrossRef
Zurück zum Zitat Sarpong A, Schottmann G, Rüther K et al. (2009) Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Clin Genet 76:38–45PubMedCrossRef Sarpong A, Schottmann G, Rüther K et al. (2009) Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Clin Genet 76:38–45PubMedCrossRef
Zurück zum Zitat Siintola E, Lehesjoki AE, Mole SE (2006) Molecular genetics of the NCLs – status and perspectives. Biochim Biophys Acta 1762:857–864PubMed Siintola E, Lehesjoki AE, Mole SE (2006) Molecular genetics of the NCLs – status and perspectives. Biochim Biophys Acta 1762:857–864PubMed
Zurück zum Zitat The International Batten Disease (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82:949–957CrossRef The International Batten Disease (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82:949–957CrossRef
Zurück zum Zitat Uvebrant P, Hagberg B (1997) Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics 28:6–8PubMedCrossRef Uvebrant P, Hagberg B (1997) Neuronal ceroid lipofuscinoses in Scandinavia. Epidemiology and clinical pictures. Neuropediatrics 28:6–8PubMedCrossRef
Zurück zum Zitat Wisniewski KE, Zhong N, Kaczmarski W et al. (1998a) (1998a) Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Ann Neurol 43:106–110PubMedCrossRef Wisniewski KE, Zhong N, Kaczmarski W et al. (1998a) (1998a) Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis. Ann Neurol 43:106–110PubMedCrossRef
Zurück zum Zitat Wisniewski KE, Zhong N, Kaczmarski W, Kaczmarski A, Sklower-Brooks S, Brown WT (1998b) Studies of atypical JNCL suggest overlapping with other NCL forms. Pediatr Neurol 18:36–40PubMedCrossRef Wisniewski KE, Zhong N, Kaczmarski W, Kaczmarski A, Sklower-Brooks S, Brown WT (1998b) Studies of atypical JNCL suggest overlapping with other NCL forms. Pediatr Neurol 18:36–40PubMedCrossRef
Zurück zum Zitat Wisniewski KE, Kaczmarski A, Kida E et al. (1999) Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab 66:248–252PubMedCrossRef Wisniewski KE, Kaczmarski A, Kida E et al. (1999) Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. Mol Genet Metab 66:248–252PubMedCrossRef
Zurück zum Zitat Wisniewski KE, Kida E, Connell F, Zhong N et al. (2000) Neuronal ceroid lipofuscinoses: research update. Neurol Sci 21(3 Suppl):S49–S56PubMedCrossRef Wisniewski KE, Kida E, Connell F, Zhong N et al. (2000) Neuronal ceroid lipofuscinoses: research update. Neurol Sci 21(3 Suppl):S49–S56PubMedCrossRef
Metadaten
Titel
Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients
verfasst von
María-Socorro Pérez-Poyato
Montserrat Milà Recansens
Isidre Ferrer Abizanda
Raquel Montero Sánchez
Laia Rodríguez-Revenga
Victoria Cusí Sánchez
M. Mar García González
Rosario Domingo Jiménez
Rafael Camino León
Ramón Velázquez Fragua
Antonio Martínez-Bermejo
Mercè Pineda Marfà
Publikationsdatum
01.10.2011
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 5/2011
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9323-7

Weitere Artikel der Ausgabe 5/2011

Journal of Inherited Metabolic Disease 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.